Jim Moriarty Email & Phone Number

Bedford, MA, US

Minneapolis, MN, US

Marlborough, Massachusetts, US

• First hire for the disposable product development effort; grew group from ground up.
• Hired staff of 5 across varied experience levels to yield a balanced group with excellent team dynamics.
• Developed an endoscope compatible catheter system from concept, document creation, supplier builds, and verification testing resulting in 510k submission and approval by Dec 2011.
• Partnered with design firm to define industrial design and GUI interface.
• Gathered input from physician customers and coordinated pre-clinical studies.
• Trained physicians conducting clinical trials in the use of the product.

• Returned to the Coronary/Peripheral Business Unit to drive innovation.
• Proposed and implemented an ethnography program to determine unmet customer needs. Program reintroduced the engineer with the customer.
• Proposed and implemented an improved patent review process with more of a business focus.
• On Coronary Product Development Process harmonization team that merged the Coronary/Peripheral and Structural Heart processes into one cohesive effort.
• Worked across business unit boundaries to settle on design traceability procedures.
• Continued pattern of involvement in due diligence activities.

• Site leader for Danvers Structural Heart which focused on technology development and feasibility.
• Site leader for team which conceptualized, completed design and in-vitro testing, and completed chronic in-vivo animal work to enable “first in man” for a permanent coronary implant. This treatment had never been done.
• Participated on multiple due diligence teams providing input on R&D, Product Development Process, and Operations.
• Coordinated a cross-functional proposal for transcatheter mitral repair and replacement.
• Directed vascular closure effort which met all scope, schedule, and cost milestones.

• Member of the Vascular division’s ventures management team, chartered with identifying opportunities to obtain new clinical indications for new or existing technologies. Worked with group in CA to identify, evaluate.
• Established cross-functional scouting activities focusing on filling a gap in the strategic plan. Team identified two different program concepts that the ventures core team put forward as recommended new programs.
• Coordinated the Vascular division’s efforts, including stent and delivery system design on virtual cross-site, cross-divisional program. Group completed risk mitigation effort to bring stents and delivery systems.
• Established and executed a plan to build an additional cross-functional 8-member pulmonic effort in the Danvers facility including: R&D, Advanced Manufacturing Engineering, and QA.
• Responsible for the Advanced Technology group where a staff of 8 took concepts through proof of principle in appropriate animal models. Team worked to develop a mitral valve repair concept.
• Served as a member of the senior staff in the Danvers facility.

• Took on Product Development Responsibility for Endovascular Innovations, a business that generated $200MM revenue. This group developed products for the treatment of abdominal and thoracic aortic aneurism.
• Group finished development of new graft delivery system and launched Talent Xcelerant product ahead of schedule.
• Directed multiple program teams (listed below) in a matrixed environment via individual team leaders, regardless of the team leader’s function.oTalent Abdominal Aortic Aneurism delivery system improvement.oNext.
• Realigned group to focus on long term goals in addition to the short term goals by establishing a renewed focus on technology development.
• Took over group with staff of over 40 and established a plan to expand the group by over 33% over the next year.

• Responsible for the development of new peripheral products including self-expanding stents, balloon expandable stents, and associated delivery systems from concept to full commercialization.
• Instituted a turn around; from a culture of developing “me too” products to developing innovative, market leading products, which resulted in improved collaboration, morale, and execution.
• Developed a staff of approximately 15. Added 8 new hires.
• Directed multiple program teams via individual team leaders.oSuccessfully launched and exceeded plan of Aurora self expanding stent.oSuccessfully launched Racer balloon expandable stent leveraging off the new Cobalt.

Minneapolis, MN, US

• Program Manager leading team responsible for successful commercialization of the Driver coronary stent system, responsible for bringing together all of the various separate functional areas needed.o Driver stent.
• Had functional responsibility for the technical development of new coronary delivery systems including shafts, balloons and new materials.
• Managed multi-site product development team split by 6000 miles and international boundaries.
• Established multiple sub-teams allowing parallel development of multiple design options.
• Group developed a rapid exchange perfusion catheter as a backup position.

Minneapolis, MN, US

• Accepted 2 year expatriate assignment and transferred to Galway, Ireland
• Responsible for the on-load of modular stent programs into Galway. In addition, the group functioned as the international build conduit for initial human use builds.
• S7 Modular stent successfully commercialized in an international environment.
• Preparation made for on-load of B2 Rx Perfusion delivery system into Galway, Ireland.
• Gained clinical experience dealing with physicians while visiting catheter labs.

• Acquired by Medtronic - 99
• Responsible for R&D activities in the areas of Extrusion, Balloons and Coatings. Staff included 11 engineers and 7 technicians.
• Took on 1 month assignment in Santa Rosa, CA, leading the technical team solving a balloon failure issue.
• Collaborated with internal customers on project plans and determined how to fill requests while balancing global priorities.

Murray Hill, New Jersey, US

• Cath lab business acquired by Arterial Vascular Engineering - 98
• Developed and implemented extrusion sub-assemblies that enabled multiple angioplasty products.
• Technical coordinator of a joint development program with DuPont.
• Provided technical and strategic direction to the group.
• Managed a staff of 3 to 5 engineers and 3 to 4 technicians.

Ms, Plastics Engineering

Executive Certificate, Technology, Operations, And Value Chain Management

Greater Boston Executive Program

Bs, Plastic Engineering